Highly selective fusion and accumulation of hybrid liposomes into primary effusion lymphoma cells along with induction of apoptosis

Biochemical and Biophysical Research Communications

Volumn 393, Issue 3, 2010, Pages 445-448

  Towata, Tomomi ^a,b   Komizu, Yuji ^a   Suzu, Shinya ^b   Ueoka, Ryuichi ^a   Okada, Seiji ^b  

^a SOJO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Caspase 3; Hybrid liposome; Membrane fluidity; Primary effusion lymphoma

Indexed keywords

CASPASE 3; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DODECYL ETHER; ETHER DERIVATIVE; LIPOSOME; POLYOXYETHYLENE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEMBRANE FLUIDITY; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; TUMOR CELL;

APOPTOSIS; CELL LINE, TUMOR; CELL MEMBRANE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; HUMANS; LIPOSOMES; LYMPHOMA, PRIMARY EFFUSION; MEMBRANE FLUIDITY; MEMBRANE FUSION; POLYETHYLENE GLYCOLS;

HUMAN HERPESVIRUS 8;

EID: 77949264888     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.016     Document Type: Article

References (20)

1. Cesarman E., Chang Y., Moore P.S., Said J.W., and Knowles D.M. Kaposi's sarcoma-associated herpes virus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332 (1995) 1186-1191
2. Chen Y.B., Rahemtullah A., and Hochberg E. Primary effusion lymphoma. Oncologist 12 (2007) 569-576
3. Nador R.G., Cesarman E., Chadburn A., Dawson D.B., Ansari M.Q., Sald J., and Knowles D.M. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88 (1996) 645-656
4. Ueoka R., Matsumoto Y., Moss R.A., Swarup S., Sugii A., Harada K., Kikuchi J., and Murakami Y. Membrane matrix for the hydrolysis of amino acid esters with marked enantioselectivity. J. Am. Chem. Soc. 110 (1988) 1588-1595
5. Ueoka R., Moss R.A., Swarup S., Matsumoto Y., Strauss G., and Murakami Y. Extraordinary micellar enantioselectivity coupled to altered aggregate structure. J. Am. Chem. Soc. 107 (1985) 2185-2186
6. Matsumoto Y., Imamura C., Ito T., Taniguchi C., and Ueoka R. Specific hybrid liposomes composed of phosphatidylcholine and polyoxyethylenealkyl ether with markedly enhanced inhibitory effects on the growth of tumor cells in vitro. Biol. Pharm. Bull. 18 (1995) 1456-1458
7. Matsumoto Y., Kato T., Iseki S., Suzuki H., Nakano K., Iwahara M., and Ueoka R. Remarkably enhanced inhibitory effects of hybrid liposomes on the growth of specific tumor cells. Bioorg. Med. Chem. Lett. 9 (1999) 1937-1940
8. Matsumoto Y., Iwamoto Y., Matsushita T., and Ueoka R. Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells. Int. J. Cancer 115 (2005) 377-382
9. Ueoka R., Matsumoto Y., Kanno A., Tsuzaki K., and Ichihara H. Marked therapeutic effect of dimyristoylphosphatidylcholine liposomes on carcinoma mice model in vivo. Biol. Pharm. Bull. 23 (2000) 1262-1263
10. Kanno A., Tsuzaki K., Miyagi M., Matsumoto Y., and Ueoka R. Chemotherapy with hybrid liposomes for melanomatosis. Biol. Pharm. Bull. 22 (1999) 1013-1014
11. Kitamura I., Kochi M., Matsumoto Y., Ueoka R., Kuratsu J., and Ushio Y. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study. Cancer Res. 56 (1996) 3986-3992
12. Nagami H., Matsumoto Y., and Ueoka R. Chemotherapy with hybrid liposomes for lymphoma without drugs in vivo. Int. J. Pharm. 315 (2006) 167-172
13. T. Towata, Y. Komizu, S. Suzu, Y. Matsumoto, R. Ueoka, S. Okada, Hybrid liposomes inhibit the growth of primary effusion lymphoma in vitro and in vivo, Leuk. Res, doi:10.1016/j.leukres.2009.12.010.
14. Shimoda S., Ichihara H., Matsumoto Y., and Ueoka R. Chemotherapy with hybrid liposomes for human breast tumors along with apoptosis in vivo. Int. J. Pharm. 372 (2009) 162-168
15. Levanon A., Kohn A., and Inbar M. Increase in lipid fluidity of cellular membranes induced by adsorption of RNA and DNA virions. J. Virol. 22 (1977) 353-360
16. Prendergast F.G., Haugland R.P., and Callahan P.J. 1-[4-(Trimethylamino)phenyl]-6-phenylhexa-1, 3,5-triene: synthesis, fluorescence properties, and use as a fluorescence probe of lipid bilayers. Biochemistry 20 (1981) 7333-7338
17. Komoriya A., Packard B.Z., Brown M.J., Wu M.L., and Henkart P.A. Assessment of caspase activities in intact apoptotic thymocytes using cell-permeable fluorogenic caspase substrates. J. Exp. Med. 191 (2000) 1819-1828
18. Fujimoto K., Iwasaki C., Kawaguchi H., Yasugi E., and Oshima M. Cell membrane dynamics and the induction of apoptosis by lipid compounds. FEBS Lett. 446 (1999) 113-116
19. Jessel R., Haertel S., Socaciu C., Tykhonova S., and Diehl H.A. Kinetics of apoptotic markers in exogenously induced apoptosis of EL4 cells. J. Cell. Mol. Med. 6 (2002) 82-92
20. Lacour S., Hammann A., Grazide S., Lagadic-Gossmann D., Athias A., Sergent O., Laurent G., Gambert P., Solary E., and Dimanche-Boitrel M.T. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res. 64 (2004) 3593-3598